New diabetes screening guidelines released

October 16, 2012

Routine screening for type 2 diabetes in adults at low and moderate risk is not recommended, although it is recommended for people at high and very high risk of the disease, state new diabetes screening guidelines published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/content/184/15/1687.full. The guidelines suggest using a risk calculator and then screening based on the predicted risk of diabetes.

"These new guidelines bring precision and convenience with web-based risk calculators and nonfasting A1C to diabetes screening," states Dr. Kevin Pottie with coauthors. "Leveraging these tools will help improve health outcomes by empowering patients to take an active role in managing and modifying their own risk factors through interventions like diet and exercise."

The guidelines, based on the latest evidence including a large published Oct. 4, 2012), are an update to the 2005 Canadian Task Force on Preventive Health Care guidelines. Aimed at physicians and policy-makers, the guidelines contain for type 2 diabetes in asymptomatic adults at low to moderate risk of diabetes as well as people at high and very high risk.

"The guidelines highlight the need to focus on people at high and very high risk as prevalence rates of diabetes increase. Even in this group there is little evidence that frequent screening is beneficial, especially for reducing mortality," added the task force, "There was no evidence to support routine screening with a blood test for type 2 diabetes among adults at low or moderate risk of diabetes. Screening this population may lead to overdiagnosis, inappropriate investigation and treatment, and unnecessary psychosocial and economic costs."

The guidelines recommend using the nonfasting A1C as the blood test to screen, which will enable physicians to screen and monitor using the same test and is easier for patients who will not need to fast for the test.

Key recommendations:

  • Use a to determine the risk level for the general population rather than apply a blood test across the board.
  • No with blood tests for adults unless at high or very high risk of diabetes.
  • For adults at high risk of diabetes, screen every 3-5 years using A1C blood test.
  • For adults at very high risk of diabetes, screen annually using A1C blood test.
  • The Finnish Diabetes Risk Score (FINDRISC) is the preferred tool for screening, and the Canadian Diabetes Risk Assessment Questionnaire (CANRISK) is an acceptable alternative.
In 2008/09, an estimated 2.4 million Canadians (6.8% of the population) had either type 1 or confirmed and another 480 000 (1.4%) did not know they had the disease. Diabetes is increasing in the population and significant increases are expected over the next 10 years. Diabetes has significant health consequences and is strongly associated with vascular disease. Applying the risk calculators with or without follow-up blood testing offers an opportunity for Canadians to address their overall risk profile for vascular disease, including .

In addition to the full guidelines, one-page information pieces and screening algorithms are available for both physicians and patients on the task force website: www.canadiantaskforce.ca

The Canadian Task Force on Preventive Health Care is an independent body of 14 primary care and prevention experts. The task force has been established by the Public Health Agency of Canada to develop clinical practice guidelines that support primary care providers in delivering preventive health care.

Explore further: 2 tests better than 1 to diagnose diabetes in overweight children

Related Stories

2 tests better than 1 to diagnose diabetes in overweight children

May 2, 2011
A new study found that the recommended blood test may not be enough to catch type 2 diabetes in overweight children, missing more than two-thirds of children at high-risk for the condition. Researchers from Children's Mercy ...

New breast cancer screening guidelines released

November 21, 2011
New breast cancer screening guidelines for women at average risk of breast cancer, published in CMAJ (Canadian Medical Association Journal), recommend no routine mammography screening for women aged 40-49 and extend the screening ...

American Diabetes Association's preferred testing method fails to identify kids with diabetes

November 21, 2011
In 2009, the American Diabetes Association (ADA) recommended that Hemoglobin A1c be exclusively used for the diagnosis of diabetes in children. The simple test measures longer-term blood sugar levels -- without requiring ...

New guidelines say no to screening EKGs for low-risk patients

July 30, 2012
(HealthDay) -- A top U.S. advisory panel has recommended against preventive electrocardiography (EKG) screening for people at low risk of heart disease.

Elderly diabetes patients with very low glucose levels have slightly increased risk of death

April 18, 2011
A new study of older diabetes patients has found that well-controlled blood sugar levels were associated with a lower risk of major complications such as heart attacks, amputation and kidney disease, but the very lowest blood ...

Recommended for you

Pancreatic islets study may spur diabetes treatment advances

September 22, 2017
Investigators in the Vanderbilt Diabetes Research and Training Center (VDRTC) and collaborators at Stanford University have discovered new insights into the molecular mechanisms of cell proliferation in juvenile human pancreatic ...

Finding a natural defense against clogged arteries

September 20, 2017
In type 2 diabetes, chronic inflammation drives cardiovascular disease, the leading cause of death among people with the condition. Researchers at Joslin Diabetes Center now have identified an unexpected natural protective ...

Study identifies blood vessel as a therapeutic target for diabetes

September 14, 2017
Blood vessels have an often overlooked role of regulating the transfer of nutrients from the blood to organs in the body. In a new Yale-led study, researchers have identified a role of a secreted protein, apelin, in regulating ...

Drug for type 2 diabetes provides significant benefits to type 1 diabetic patients

September 14, 2017
A majority of patients with Type 1 diabetes who were treated with dapagliflozin, a Type 2 diabetes medicine, had a significant decline in their blood sugar levels, according to a new study published in The Lancet Diabetes ...

Epigenetic 'fingerprint' identifies diabetes risk

September 14, 2017
Deakin researchers have identified an epigenetic marker that predicts risk of type 2 diabetes in women with gestational diabetes.

Could swine flu be linked to type 1 diabetes?

September 14, 2017
(HealthDay)—Young people who've been infected with the H1N1 swine flu virus may be at increased risk for type 1 diabetes, a new study suggests.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.